Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy

BACKGROUND: Muscular dystrophy (MD) causes a progressive cardiomyopathy characterized by diffuse fibrosis, arrhythmia, heart failure, and early death. Activation of the thromboxane‐prostanoid receptor (TPr) increases calcium transients in cardiomyocytes and is proarrhythmic and profibrotic. We hypot...

Descripción completa

Detalles Bibliográficos
Autores principales: West, James D., Galindo, Cristi L., Kim, Kyungsoo, Shin, John Jonghyun, Atkinson, James B., Macias‐Perez, Ines, Pavliv, Leo, Knollmann, Bjorn C., Soslow, Jonathan H., Markham, Larry W., Carrier, Erica J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898850/
https://www.ncbi.nlm.nih.gov/pubmed/31662020
http://dx.doi.org/10.1161/JAHA.118.011902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898850/
https://www.ncbi.nlm.nih.gov/pubmed/31662020
http://dx.doi.org/10.1161/JAHA.118.011902

Ejemplares similares